Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma

por Baertsch, Marc-Andrea, Fougereau, Mathilde, Hielscher, Thomas, Sauer, Sandra, Breitkreutz, Iris, Jordan, Karin, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Raab, Marc-Steffen, Hillengass, Jens, Giesen, Nicola
Publicado 2021

Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1

por Wagner, Verena, Hose, Dirk, Seckinger, Anja, Weiz, Ludmila, Meißner, Tobias, Rème, Thiery, Breitkreutz, Iris, Podar, Klaus, Ho, Anthony D., Goldschmidt, Hartmut, Krämer, Alwin, Klein, Bernard, Raab, Marc S.
Publicado 2014

Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma

por Okawa, Yutaka, Hideshima, Teru, Ikeda, Hiroshi, Raje, Noopur, Vallet, Sonia, Kiziltepe, Tanyel, Yasui, Hiroshi, Enatsu, Sotaro, Pozzi, Samantha, Breitkreutz, Iris, Cirstea, Diana, Santo, Loredana, Richardson, Paul, Anderson, Kenneth C.
Publicado 2008

Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report

por Feurstein, Simone, Zoller, Julian, Schwab, Constantin, Schreiner, Sarah, Mundt, Heiko, Breitkreutz, Iris, Schneider, Brigitte, Beimler, Jörg, Zeier, Martin, Waldherr, Rüdiger, Gröschel, Stefan, Müller‐Tidow, Carsten, Schönland, Stefan O., Hegenbart, Ute
Publicado 2022